Board of Directors Recommended Final Dividend of INR 11 per share for the FY 2025-26, Subject to approval of Shareholders
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hester Biosciences Board has recommended a final dividend of INR 11 per equity share (110% on INR 10 face value) for FY 2025-26, subject to shareholder approval at the AGM. For FY26, standalone profit after tax surged 63.6% to INR 521 million from INR 318.42 million in FY25, while consolidated profit nearly doubled to INR 574.84 million from INR 288.26 million. Standalone revenue grew modestly to INR 2,921.36 million from INR 2,864.66 million. The company also divested its 43.81% stake in subsidiary Texas Lifescience Private Limited in March 2026. Ms. Priya Gandhi, daughter of CEO Rajiv Gandhi, was reappointed as Executive Director for 3 years from October 2026.
The strong profit growth and dividend recommendation signal company health and shareholder returns. Investors holding shares before the record date will receive INR 11 per share if approved at the AGM.